SAR288 has emerged as a potential therapeutic target for COVID-19. This small molecule exhibits significant antiviral properties against SARS-CoV-2, the virus responsible for COVID-19. Preclinical studies have https://pennyppzx063019.pointblog.net/a-novel-therapeutic-target-for-covid-19-86931610